Literature DB >> 19790046

The melanocortin system in articular chondrocytes: melanocortin receptors, pro-opiomelanocortin, precursor proteases, and a regulatory effect of alpha-melanocyte-stimulating hormone on proinflammatory cytokines and extracellular matrix components.

Susanne Grässel1, Alfred Opolka, Sven Anders, Rainer H Straub, Joachim Grifka, Thomas A Luger, Markus Böhm.   

Abstract

OBJECTIVE: The pro-opiomelanocortin (POMC)-derived neuropeptide alpha-melanocyte-stimulating hormone (alpha-MSH) mediates its effects via melanocortin (MC) receptors. This study was carried out to investigate the expression patterns of the MC system and the effects of alpha-MSH in human articular chondrocytes.
METHODS: Articular chondrocytes established from human osteoarthritic joint cartilage were analyzed by reverse transcription-polymerase chain reaction (RT-PCR) and Western blotting for the expression of MC receptors, POMC, and prohormone convertases (PCs). MC-1 receptor (MC-1R) expression in articular cartilage was further studied by immunohistochemistry. Ca(2+) and cAMP assays were used to monitor alpha-MSH signaling, while studies of alpha-MSH function were performed in cultures with chondrocyte micromass pellets stimulated with alpha-MSH. Expression of cytokines and extracellular matrix (ECM) components was determined by real-time RT-PCR, Western immunoblotting, and enzyme-linked immunosorbent assays.
RESULTS: MC-1R expression was detected in articular chondrocytes in vitro and in articular cartilage in situ. In addition, expression of transcripts for MC-2R, MC-5R, POMC, and PCs was detected in articular chondrocytes. Stimulation with alpha-MSH increased the levels of intracellular cAMP, but not Ca(2+), in chondrocytes. Both messenger RNA and protein expression of various proinflammatory cytokines, collagens, matrix metalloproteinases (MMPs), and SOX9 was modulated by alpha-MSH.
CONCLUSION: Human articular chondrocytes are target cells for alpha-MSH. The effects of alpha-MSH on expression of cytokines and MMPs suggest that this neuropeptide plays a role in inflammatory and degenerative processes in cartilage. It is conceivable that inflammatory reactions can be mitigated by the induction of endogenous MCs or administration of alpha-MSH to the affected joints. The induction pattern of regulatory and structural ECM components such as collagens as well as SOX9 and anabolic and catabolic cytokines points to a function of alpha-MSH as a trophic factor in skeletal development during endochondral ossification rather than as a factor in homeostasis of permanent cartilage.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19790046     DOI: 10.1002/art.24846

Source DB:  PubMed          Journal:  Arthritis Rheum        ISSN: 0004-3591


  20 in total

1.  Chondroprotective and anti-inflammatory role of melanocortin peptides in TNF-α activated human C-20/A4 chondrocytes.

Authors:  Magdalena K Kaneva; Mark J P Kerrigan; Paolo Grieco; G Paul Curley; Ian C Locke; Stephen J Getting
Journal:  Br J Pharmacol       Date:  2012-09       Impact factor: 8.739

Review 2.  Role of proopiomelanocortin-derived peptides and their receptors in the osteoarticular system: from basic to translational research.

Authors:  Markus Böhm; Susanne Grässel
Journal:  Endocr Rev       Date:  2012-06-26       Impact factor: 19.871

Review 3.  Opioid system and Alzheimer's disease.

Authors:  Zhiyou Cai; Anna Ratka
Journal:  Neuromolecular Med       Date:  2012-04-22       Impact factor: 3.843

Review 4.  Immune resolution mechanisms in inflammatory arthritis.

Authors:  Mauro Perretti; Dianne Cooper; Jesmond Dalli; Lucy V Norling
Journal:  Nat Rev Rheumatol       Date:  2017-01-05       Impact factor: 20.543

Review 5.  Role of melanocortin receptors in the regulation of gouty inflammation.

Authors:  Trinidad Montero-Melendez; Hetal B Patel; Mauro Perretti
Journal:  Curr Rheumatol Rep       Date:  2011-04       Impact factor: 4.592

6.  α-Melanocyte-stimulating-hormone (α-MSH) modulates human chondrocyte activation induced by proinflammatory cytokines.

Authors:  Franco Capsoni; Anna Maria Ongari; Caterina Lonati; Riccardo Accetta; Stefano Gatti; Anna Catania
Journal:  BMC Musculoskelet Disord       Date:  2015-06-21       Impact factor: 2.362

7.  MC1R is dispensable for the proteinuria reducing and glomerular protective effect of melanocortin therapy.

Authors:  Yingjin Qiao; Anna-Lena Berg; Pei Wang; Yan Ge; Songxia Quan; Sijie Zhou; Hai Wang; Zhangsuo Liu; Rujun Gong
Journal:  Sci Rep       Date:  2016-06-08       Impact factor: 4.379

8.  Association between periodontal disease and inflammatory arthritis reveals modulatory functions by melanocortin receptor type 3.

Authors:  Trinidad Montero-Melendez; Mila F M Madeira; Lucy V Norling; Asil Alsam; Michael A Curtis; Tarcília A da Silva; Mauro Perretti
Journal:  Am J Pathol       Date:  2014-06-27       Impact factor: 4.307

9.  Curbing Inflammation through Endogenous Pathways: Focus on Melanocortin Peptides.

Authors:  Tazeen J Ahmed; Trinidad Montero-Melendez; Mauro Perretti; Costantino Pitzalis
Journal:  Int J Inflam       Date:  2013-05-07

10.  Melanocortin 1 receptor-signaling deficiency results in an articular cartilage phenotype and accelerates pathogenesis of surgically induced murine osteoarthritis.

Authors:  Julia Lorenz; Elisabeth Seebach; Gerit Hackmayer; Carina Greth; Richard J Bauer; Kerstin Kleinschmidt; Dominik Bettenworth; Markus Böhm; Joachim Grifka; Susanne Grässel
Journal:  PLoS One       Date:  2014-09-05       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.